Categories AlphaGraphs, Earnings, Other Industries
Alaska Air Q2 earnings rise 31% on traffic growth, exceed estimates
Benefitting from an increase in passenger traffic, Alaska Air Group (NYSE: ALK) reported stronger than expected earnings for the second quarter. Revenues rose 6% and came in slightly above estimates.
Revenue passenger miles, a measure of passenger traffic, rose 1% from last year to 14.64 billion during the June quarter. At 16.98 billion, capacity, or available seat miles, was up 1% year-over-year.
Reflecting the traffic growth, total revenues advanced 6% to $2.29 billion and came in slightly above the consensus forecast. Total load factor edged up by 0.2 points to 86.2% during the period.
Related: JetBlue’s Q2 results beat market expectations
Second-quarter earnings, excluding one-off items, rose to $2.17 per share from $1.66 per share last year. Unadjusted profit was $262 million or $2.11 per share, compared to $193 million or $1.56 per share in the second quarter of 2018. Analysts were looking for a lower profit.
“The three-percentage point improvement in our adjusted pretax margin shows that our revenue initiatives and cost management efforts are paying off. We set an ambitious plan and are executing it. But what our people really do best is provide genuine, caring service for our guests, and that’s why they earned our 12th-straight J.D. Power award this year,” said Alaska CEO Brad Tilden.
During the quarter, the company paid a quarterly cash dividend of 0.35$ per share, representing a 9% increase compared to the same period of last year. In the year-to-date period, it repurchased 408,665 shares of common stock for about $25 million.
Earlier this month, the airline’s technicians, represented by the Aircraft Mechanics Fraternal Association, approved the integrated seniority list and a transition agreement, including a two-year contract extension.
Shares of Alaska Air closed Thursday’s regular session sharply lower. The stock has gained about 19% since mid-march when it slipped to the lowest level in more than four years. Currently, it is trading close to the levels seen a year earlier.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on